Veradermics Inc (MANE)

$37.16 -0.59 (-1.56%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 934,600
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Veradermics, Incorporated operates as a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA...

Industry: Biotechnology
Sector: Healthcare
Phone: (228) 372-3376
Address:
470 James Street, Suite 14, New Haven, United States
Culby
Culby Mar. 17 at 6:17 PM
$MANE apparently all this does is go up??
0 · Reply
IN0V8
IN0V8 Mar. 3 at 6:39 PM
$MANE 3/2 Buy Citigroup initiates coverage with buy ?rating; target price $85 Jefferies initiates coverage with buy rating; target price $75 Leerink Partners initiates coverage with outperform rating Leerink Partners initiates coverage with target price $75
0 · Reply
erevnon
erevnon Mar. 2 at 3:57 PM
Citigroup initiates coverage on Veradermics $MANE at Buy rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
xelaxela
xelaxela Feb. 19 at 11:52 PM
$MANE Seems like nobody is trading this thing
0 · Reply
THSSKS
THSSKS Feb. 8 at 5:20 PM
$MANE massively underfunded and overvalued bioturd, but huge tam for mpb. Company is essentially broke, if investment bankers push it up for an offering, I’ll be shorting the hell outta this time released rogaine stock.
1 · Reply
Pranee2023
Pranee2023 Feb. 6 at 7:28 PM
$MANE oral minoxidil.
0 · Reply
JayBullsEye
JayBullsEye Feb. 5 at 2:14 PM
$MANE
0 · Reply
VinnyVelvet
VinnyVelvet Feb. 5 at 5:43 AM
$MANE How we feeling about his today?
0 · Reply
Latest News on MANE
Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting

Mar 18, 2026, 7:00 AM EDT - 3 days ago

Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting

Veradermics, Incorporated (MANE) Presents at Leerink Global Healthcare Conference 2026 Transcript

Mar 16, 2026, 8:42 PM EDT - 4 days ago

Veradermics, Incorporated (MANE) Presents at Leerink Global Healthcare Conference 2026 Transcript

Veradermics to Participate in Upcoming March Investor Conferences

Mar 3, 2026, 7:00 AM EST - 18 days ago

Veradermics to Participate in Upcoming March Investor Conferences

NYSE Content Update: Forgent Power Solutions, Post IPO, to Ring Opening Bell

Feb 12, 2026, 8:55 AM EST - 5 weeks ago

NYSE Content Update: Forgent Power Solutions, Post IPO, to Ring Opening Bell

FPS

Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss

Feb 9, 2026, 7:30 AM EST - 5 weeks ago

Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss

U.S. IPO Weekly Recap: 7 IPOs Make It One Of The Busiest Weeks In 4 Years

Feb 6, 2026, 10:00 PM EST - 6 weeks ago

U.S. IPO Weekly Recap: 7 IPOs Make It One Of The Busiest Weeks In 4 Years

AGBK AGMB OXY ARKO BOBS CEPS EIKN

Veradermics Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering

Feb 5, 2026, 4:05 PM EST - 6 weeks ago

Veradermics Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering

Veradermics Announces Pricing of Upsized Initial Public Offering

Feb 3, 2026, 9:57 PM EST - 6 weeks ago

Veradermics Announces Pricing of Upsized Initial Public Offering

Veradermics Finalizes $200 Million IPO Target

Feb 2, 2026, 1:28 PM EST - 6 weeks ago

Veradermics Finalizes $200 Million IPO Target

Veradermics, Dermatology Biopharma Focused on Hair Loss, Files for NYSE IPO

Jan 9, 2026, 5:08 PM EST - 2 months ago

Veradermics, Dermatology Biopharma Focused on Hair Loss, Files for NYSE IPO

Veradermics IPO Registration Document (S-1)

Jan 9, 2026, 5:04 PM EST - 2 months ago

Veradermics IPO Registration Document (S-1)

Hair loss biotech Veradermics files for a $100 million IPO

Jan 9, 2026, 3:13 PM EST - 2 months ago

Hair loss biotech Veradermics files for a $100 million IPO

Culby
Culby Mar. 17 at 6:17 PM
$MANE apparently all this does is go up??
0 · Reply
IN0V8
IN0V8 Mar. 3 at 6:39 PM
$MANE 3/2 Buy Citigroup initiates coverage with buy ?rating; target price $85 Jefferies initiates coverage with buy rating; target price $75 Leerink Partners initiates coverage with outperform rating Leerink Partners initiates coverage with target price $75
0 · Reply
erevnon
erevnon Mar. 2 at 3:57 PM
Citigroup initiates coverage on Veradermics $MANE at Buy rating and announces a price target of https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
xelaxela
xelaxela Feb. 19 at 11:52 PM
$MANE Seems like nobody is trading this thing
0 · Reply
THSSKS
THSSKS Feb. 8 at 5:20 PM
$MANE massively underfunded and overvalued bioturd, but huge tam for mpb. Company is essentially broke, if investment bankers push it up for an offering, I’ll be shorting the hell outta this time released rogaine stock.
1 · Reply
Pranee2023
Pranee2023 Feb. 6 at 7:28 PM
$MANE oral minoxidil.
0 · Reply
JayBullsEye
JayBullsEye Feb. 5 at 2:14 PM
$MANE
0 · Reply
VinnyVelvet
VinnyVelvet Feb. 5 at 5:43 AM
$MANE How we feeling about his today?
0 · Reply